Which pharmaceutical company launched the first major insulin subscription program in 2019 that allowed patients to pay a flat monthly fee for their insulin regardless of dosage needs?

The healthcare industry has been evolving with innovative payment and access models for medications. Subscription-based models for pharmaceuticals have emerged as an alternative to traditional one-time purchases, especially for chronic condition management. This poll tests your knowledge about a groundbreaking subscription service in the medical industry that changed how patients access vital medications.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

• Novo Nordisk with 'NovoSub'
• Eli Lilly with 'Insulin Value Program'
• Sanofi with 'InsulinRx Subscription'
• Pfizer with 'DiabetesCare Monthly'

Powered by AIPolls.Net — AI-powered real-time polling platform.